Related Experiment Video
Updated: Apr 8, 2026
05:24
Author Spotlight: Improving the Production of Self-Assembling Fibers and Peptide Hydrogels for Superior Biocompatibility
Published on: September 6, 2024
1.8K
[Application of Self-assembling Peptides to Hemostasis]
Hui Gan1, Zhi-Yun Meng1, Zhuo-Na Wu1
1Institute of Transfusion Medicine, Academy of Military Medical Sciences, Beijing 100850, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|June 29, 2015
Summary
Self-assembling peptides (SAP) show great potential for tissue engineering and medicine due to their remarkable hemostatic effects on various wounds. This review explores SAP characteristics, mechanisms, and future trends in hemostasis.
Area of Science:
- Molecular self-assembly is a multidisciplinary field merging chemistry, biology, materials science, and medicine.
Context:
- Peptide self-assembly technology is rapidly advancing, showing significant potential in tissue engineering, drug delivery, bionic medicine, and optoelectronics.
- Self-assembling peptides (SAP) demonstrate remarkable hemostatic effects, particularly on organ, nerve, and brain wounds, driving their application in materials science and clinical medicine.
Purpose:
- This review focuses on the hemostatic effects and characteristics of SAP across various bleeding wound models.
- It examines the action mechanisms, benefits, limitations, and future trends of SAP in hemostasis.
Summary:
- SAP exhibit potent hemostatic properties, making them promising for advanced wound management and regenerative medicine.
- Their ability to self-assemble into functional structures underpins their diverse applications.
Impact:
- SAP offer innovative solutions for clinical hemostasis, potentially improving patient outcomes in surgery and trauma care.
- This research highlights the translational potential of peptide self-assembly from materials science to clinical applications.
Related Concept Videos
01:05Introduction to Hemostasis
17.4K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
17.4K
01:22Formation of the Platelet Plug
10.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.8K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
15.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
15.6K
01:09Coagulation
12.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
12.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
01:16Clot Retraction and Fibrinolysis
10.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
10.3K